Synthesis of Piperazinephen-1-ylethylamines as Potent and Selective Antagonists of the Human Melanocortin-4 Receptor

E-ISSN： 1875-628x|3|5|311-315

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.5, 2006-07, pp. : 311-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Approaches to the rational design of selective melanocortin receptor antagonists

By Hruby Victor J Cai Minying Nyberg Joel Muthu Dhanasekaran

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 543-557

Informa Healthcare

Access to resources Recommend Favorite

New potent and selective human adenosine A 3 receptor antagonists

By Baraldi P.G. Borea P.A.

Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. : 456-459

Elsevier

Access to resources Recommend Favorite

Synthesis and Structure-Activity Relationships of 4,10-Dihydro-4-oxo-4HImidazo[ 1,2-a]Indeno[1,2-e]Pyrazine Derivatives: Highly Potent and Selective AMPA Receptor Antagonists with In Vivo Activity

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 2, 2004-02 ,pp. : 123-140

Bentham Science Publishers

Access to resources Recommend Favorite

Promising Strategies for Obesity Pharmacotherapy: Melanocortin-4 (MC- 4) Receptor Agonists and Melanin Concentrating Hormone (MCH) Receptor-1 Antagonists

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-04 ,pp. : 504-538

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Strategies for the Design of New Potent and Selective Human A3 Receptor Antagonists: An Update

Current Medicinal Chemistry, Vol. 13, Iss. 6, 2006-03 ,pp. : 639-645

Bentham Science Publishers

Access to resources Recommend Favorite